These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 19948527

  • 1. Antenatal corticosteroids and neonatal outcomes according to gestational age: a cohort study.
    Manktelow BN, Lal MK, Field DJ, Sinha SK.
    Arch Dis Child Fetal Neonatal Ed; 2010 Mar; 95(2):F95-8. PubMed ID: 19948527
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of a single dose of antenatal corticosteroids on morbidity and mortality of preterm infants.
    Costa S, Zecca E, De Luca D, De Carolis MP, Romagnoli C.
    Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):154-7. PubMed ID: 16797825
    [Abstract] [Full Text] [Related]

  • 3. Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation.
    Ventolini G, Neiger R, Mathews L, Adragna N, Belcastro M.
    Am J Perinatol; 2008 Feb; 25(2):79-83. PubMed ID: 18188800
    [Abstract] [Full Text] [Related]

  • 4. [Short-term respiratory outcome of late preterm newborn in a center of level III].
    Champion V, Durrmeyer X, Dassieu G.
    Arch Pediatr; 2010 Jan; 17(1):19-25. PubMed ID: 19910172
    [Abstract] [Full Text] [Related]

  • 5. Antenatal corticosteroid therapy in premature infants.
    Smrcek JM, Schwartau N, Kohl M, Berg C, Geipel A, Krapp M, Diedrich K, Ludwig M.
    Arch Gynecol Obstet; 2005 Jan; 271(1):26-32. PubMed ID: 15309401
    [Abstract] [Full Text] [Related]

  • 6. Implementing potentially better practices to improve neonatal outcomes after reducing postnatal dexamethasone use in infants born between 501 and 1250 grams.
    Kaempf JW, Campbell B, Sklar RS, Arduza C, Gallegos R, Zabari M, Brown A, McDonald JV.
    Pediatrics; 2003 Apr; 111(4 Pt 2):e534-41. PubMed ID: 12671173
    [Abstract] [Full Text] [Related]

  • 7. Effects of basic developmental care on neonatal morbidity, neuromotor development, and growth at term age of infants who were born at <32 weeks.
    Maguire CM, Veen S, Sprij AJ, Le Cessie S, Wit JM, Walther FJ, Leiden Developmental Care Project.
    Pediatrics; 2008 Feb; 121(2):e239-45. PubMed ID: 18245399
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chronic lung disease following neonatal ventilation. I. incidence in two geographically defined populations.
    Fenton AC, Annich G, Mason E, Solimano A, Field DJ.
    Pediatr Pulmonol; 1996 Jan; 21(1):20-3. PubMed ID: 8776261
    [Abstract] [Full Text] [Related]

  • 10. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study].
    Fekih M, Chaieb A, Sboui H, Denguezli W, Hidar S, Khairi H.
    Tunis Med; 2002 May; 80(5):260-5. PubMed ID: 12534029
    [Abstract] [Full Text] [Related]

  • 11. Is it safer to intubate premature infants in the delivery room?
    Aly H, Massaro AN, Patel K, El-Mohandes AA.
    Pediatrics; 2005 Jun; 115(6):1660-5. PubMed ID: 15930230
    [Abstract] [Full Text] [Related]

  • 12. Single versus repeated-course antenatal corticosteroids: outcomes in singleton and multiple-gestation pregnancies.
    Dirnberger DR, Yoder BA, Gordon MC.
    Am J Perinatol; 2001 Aug; 18(5):267-7. PubMed ID: 11552179
    [Abstract] [Full Text] [Related]

  • 13. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group.
    Ballard RA, Ballard PL, Cnaan A, Pinto-Martin J, Davis DJ, Padbury JF, Phibbs RH, Parer JT, Hart MC, Mannino FL, Sawai SK.
    N Engl J Med; 1998 Feb 19; 338(8):493-8. PubMed ID: 9468465
    [Abstract] [Full Text] [Related]

  • 14. Comparisons of mortality and pre-discharge respiratory outcomes in small-for-gestational-age and appropriate-for-gestational-age premature infants.
    Sharma P, McKay K, Rosenkrantz TS, Hussain N.
    BMC Pediatr; 2004 Jun 08; 4():9. PubMed ID: 15186501
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
    Rojas MA, Lozano JM, Rojas MX, Laughon M, Bose CL, Rondon MA, Charry L, Bastidas JA, Perez LA, Rojas C, Ovalle O, Celis LA, Garcia-Harker J, Jaramillo ML, Colombian Neonatal Research Network.
    Pediatrics; 2009 Jan 08; 123(1):137-42. PubMed ID: 19117872
    [Abstract] [Full Text] [Related]

  • 18. Antenatal steroids are associated with less need for blood pressure support in extremely premature infants.
    Moïse AA, Wearden ME, Kozinetz CA, Gest AL, Welty SE, Hansen TN.
    Pediatrics; 1995 Jun 08; 95(6):845-50. PubMed ID: 7761207
    [Abstract] [Full Text] [Related]

  • 19. Effect of preterm birth and antenatal corticosteroid treatment on lactogenesis II in women.
    Henderson JJ, Hartmann PE, Newnham JP, Simmer K.
    Pediatrics; 2008 Jan 08; 121(1):e92-100. PubMed ID: 18166549
    [Abstract] [Full Text] [Related]

  • 20. The limit of viability--neonatal outcome of infants born at 22 to 25 weeks' gestation.
    Allen MC, Donohue PK, Dusman AE.
    N Engl J Med; 1993 Nov 25; 329(22):1597-601. PubMed ID: 8179651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.